Share on StockTwits
 

Integra LifeSciences Holdings Corp. (NASDAQ:IART) is scheduled to be issuing its Q413 quarterly earnings data on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.81 per share and revenue of $223.37 million for the quarter.

Integra LifeSciences Holdings Corp. (NASDAQ:IART) traded up 0.32% on Monday, hitting $47.52. The stock had a trading volume of 67,447 shares. Integra LifeSciences Holdings Corp. has a 52 week low of $30.87 and a 52 week high of $49.90. The stock’s 50-day moving average is $47.26 and its 200-day moving average is $44.13. The company’s market cap is $1.336 billion.

IART has been the subject of a number of recent research reports. Analysts at Barclays raised their price target on shares of Integra LifeSciences Holdings Corp. from $45.00 to $50.00 in a research note on Thursday, January 9th. They now have an “equal weight” rating on the stock. On the ratings front, analysts at Bank of America upgraded shares of Integra LifeSciences Holdings Corp. to a “neutral” rating in a research note on Wednesday, January 8th. Finally, analysts at Bank of America upgraded shares of Integra LifeSciences Holdings Corp. from an “underperform” rating to a “neutral” rating in a research note on Wednesday, January 8th. Nine research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Integra LifeSciences Holdings Corp. has an average rating of “Hold” and an average target price of $46.88.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) is an integrated medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.